Biotalys N.V (BTLS) | Financial Analysis & Statements
Biotalys N.V. | Mid-cap | Basic Materials
Biotalys N.V. | Mid-cap | Basic Materials
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
0
Operating Income
-13.5M
Net Income
-13.2M
Balance Sheet Metrics
Total Assets
36.7M
Total Liabilities
9.1M
Shareholders Equity
27.6M
Debt to Equity
0.33
Cash Flow Metrics
Operating Cash Flow
-13.8M
Free Cash Flow
-12.8M
Revenue & Profitability Trend
Biotalys N.V Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 15.2M | 22.0M | 23.9M | 19.1M | 13.7M |
| Operating Income | -13.5M | -20.9M | -22.5M | -18.1M | -13.3M |
| Pre-tax Income | -13.1M | -20.5M | -22.8M | -16.9M | -10.7M |
| Income Tax | 40.0K | 56.0K | -38.0K | 16.0K | 13.0K |
| Net Income | -13.2M | -20.5M | -22.7M | -16.9M | -10.8M |
| EPS (Diluted) | - | -€0.65 | -€0.74 | -€1.10 | -€0.36 |
Income Statement Trend
Biotalys N.V Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 26.2M | 24.9M | 37.8M | 58.9M | 25.5M |
| Non-Current Assets | 10.5M | 11.7M | 11.8M | 11.3M | 10.8M |
| Total Assets | 36.7M | 36.6M | 49.5M | 70.3M | 36.3M |
| Liabilities | |||||
| Current Liabilities | 4.8M | 5.5M | 6.0M | 5.2M | 6.1M |
| Non-Current Liabilities | 4.4M | 5.5M | 5.4M | 6.2M | 4.5M |
| Total Liabilities | 9.1M | 11.0M | 11.4M | 11.4M | 10.6M |
| Equity | |||||
| Total Shareholders Equity | 27.6M | 25.6M | 38.1M | 58.9M | 25.6M |
Balance Sheet Composition
Biotalys N.V Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -13.5M | -20.9M | -22.5M | -18.1M | -13.3M |
| Operating Cash Flow | -13.8M | -17.7M | -21.8M | -17.7M | -11.8M |
| Investing Activities | |||||
| Capital Expenditures | -107.0K | -312.0K | -707.0K | -1.3M | -3.8M |
| Investing Cash Flow | -118.0K | -311.0K | -707.0K | -1.3M | -5.9M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 13.3M | 5.7M | -997.0K | 51.3M | 15.3M |
| Free Cash Flow | -12.8M | -18.7M | -20.8M | -18.1M | -13.5M |
Cash Flow Trend
Biotalys N.V Key Financial Ratios
Valuation Ratios
Forward P/E
-11.12
Price to Book
6.04
Price to Sales
52.39
PEG Ratio
-11.12
Profitability Ratios
Profit Margin
0.00%
Operating Margin
-217.37%
Return on Equity
-49.60%
Return on Assets
-23.00%
Financial Health
Current Ratio
5.50
Debt to Equity
17.56
Beta
0.91
Per Share Data
EPS (TTM)
-€0.40
Book Value per Share
€0.74
Revenue per Share
€0.10
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| btls | 166.7M | - | 6.04 | -49.60% | 0.00% | 17.56 |
| Tessenderlo Group NV | 1.5B | 35.71 | 0.80 | 2.28% | 1.62% | 13.46 |
| Anheuser-Busch InBev | 120.4B | 21.06 | 1.57 | 6.60% | 11.75% | 81.53 |
| Syneos Health | 6.9B | 377.86 | 1.03 | -1.38% | -1.59% | 28.51 |
| Azelis Group NV | 3.2B | 17.86 | 1.12 | 6.77% | 4.29% | 63.15 |
| Solvay SA | 3.1B | 15.83 | 2.26 | 14.16% | 3.88% | 155.68 |
Financial data is updated regularly. All figures are in the company's reporting currency.